What's in Oasmia Pharmaceutical AB's pipeline?

Oasmia Pharmaceutical AB has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Oasmia Pharmaceutical AB's portfolio?

Top competitors by shared drug class: Air Force Military Medical University, China, Akeso, Biotech Pharmaceutical Co., Ltd., Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Central European Society for Anticancer Drug Research.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/oasmia-pharmaceutical-ab.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Oasmia Pharmaceutical AB — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oasmia Pharmaceutical AB pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Paclical®	Paclical®	phase 3	Taxane	Microtubules	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Air Force Military Medical University, China · 1 shared drug class
Akeso · 1 shared drug class
Biotech Pharmaceutical Co., Ltd. · 1 shared drug class
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · 1 shared drug class
Central European Society for Anticancer Drug Research · 1 shared drug class
Chengdu Kanghong Biotech Co., Ltd. · 1 shared drug class
Fourth Affiliated Hospital of Guangxi Medical University · 1 shared drug class
AbbVie (prior sponsor, Abbott) · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Oasmia Pharmaceutical AB:

Cite this brief

Drug Landscape (2026). Oasmia Pharmaceutical AB — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/oasmia-pharmaceutical-ab. Accessed 2026-06-10.